National Round The Clock Hot Line
1-888-365-4458(US)  44-808-111-0143(EU)
86-108-294-5717(AS)
go to cart
1 2 3 4 5

Email Subscribe


Your Position:Home > Bio Pharmacy > China Biologics and Biosimilars Market Research Report 2017

China Biologics and Biosimilars Market Research Report 2017

Goods_sn:zq

Publishers:QYResearch

Numbers:Share

Price:

License: single license enterprise license

China Biologics and Biosimilars Market Research Report 2017

Hard Copy: 3200 USD 
PDF Copy (single user): 3200 USD
Enterprise wide License: 6400 USD
Pages: 116
Tables and Figures: 124
Published Date: Jan. 2017
Publisher: QYR Biologics and Biosimilars Research Center
Contact: Mr. Zhang Dong +1-6262952442 +86-1082945717; sales@qyresearch.com

Summary

This report studies Biologics and Biosimilars in China market, focuses on top manufacturers in China market, with capacity, production, price, revenue and market share for each manufacturer, covering
Biologics 
Amgen
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
3sbio
Changchun High and New Technology Industry
CP Guojian Pharmacy
Biotech Pharma
Gelgen Biopharma
Innovent
Tong Hua Dong Bao Group
Ganlee
United Laboratories

Biosimilars
3sbio
Changchun High and New Technology Industry
CP Guojian Pharmacy
Biotech Pharma
Gelgen Biopharma


Split by Product Types, with production, revenue, price, market share and growth rate of each type, can be divided into
Antibody
Hormone
Growth Factors
Other


Split by applications, this report focuses on consumption, market share and growth rate of Biologics and Biosimilars in each application, can be divided into
Tumor
Diabetes
Cardiovascular
Hemophilia
Other


Table of Contents

China Biologics and Biosimilars Market Research Report 2017
1 Biologics and Biosimilars Market Overview
1.1 Product Overview and Scope of Biologics and Biosimilars
1.2 Biologics and Biosimilars Segment by Types
1.2.1 China Production Market Share of Biologics and Biosimilars by Types in 2015
1.2.2 Antibody
1.2.3 Hormone
1.2.4 Growth Factors
1.2.5 Other
1.3 Biologics and Biosimilars Segment by Applications
1.3.1 Biologics and Biosimilars Consumption Market Share by Applications in 2015
1.3.2 Tumor
1.3.3 Diabetes
1.3.4 Cardiovascular
1.3.5 Hemophilia
1.3.6 Other
1.4 China Market Size (Value) of Biologics and Biosimilars (2011-2021)
1.5 China Biologics and Biosimilars Status and Outlook
1.6 Government Policies
2 China Biologics and Biosimilars Market Competition by Manufacturers
2.1 China Biologics and Biosimilars Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 China Biologics and Biosimilars Revenue and Share by Manufacturers (2015 and 2016)
2.3 China Biologics and Biosimilars Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Biologics and Biosimilars Manufacturing Base Distribution, Sales Area, Product Types
2.5 Biologics and Biosimilars Market Competitive Situation and Trends
2.5.1 Biologics and Biosimilars Market Concentration Rate
2.5.2 Biologics and Biosimilars Market Share of Top 3 and Top 5 Manufacturers
3 China Biologics and Biosimilars Manufacturers Profiles/Analysis
Biologics
3.1 Amgen
3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.1.2 Biologics and Biosimilars Product Types, Application and Specification
3.1.2.1 Antibody
3.1.2.2 Hormone
3.1.3 Amgen Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.1.4 Main Business/Business Overview
3.2 Sanofi-Aventis
3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.2.2 Biologics and Biosimilars Product Types, Application and Specification
3.2.2.1 Antibody
3.2.2.2 Hormone
3.2.3 Sanofi-Aventis Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.2.4 Main Business/Business Overview
3.3 Johnson & Johnson
3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.3.2 Biologics and Biosimilars Product Types, Application and Specification
3.3.2.1 Antibody
3.3.2.2 Hormone
3.3.3 Johnson & Johnson Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.3.4 Main Business/Business Overview
3.4 Pfizer
3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.4.2 Biologics and Biosimilars Product Types, Application and Specification
3.4.2.1 Antibody
3.4.2.2 Hormone
3.4.3 Pfizer Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.4.4 Main Business/Business Overview
3.5 Novo Nordisk
3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.5.2 Biologics and Biosimilars Product Types, Application and Specification
3.5.2.1 Antibody
3.5.2.2 Hormone
3.5.3 Novo Nordisk Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.5.4 Main Business/Business Overview
3.6 Eli Lilly
3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.6.2 Biologics and Biosimilars Product Types, Application and Specification
3.6.2.1 Antibody
3.6.2.2 Hormone
3.6.3 Eli Lilly Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.6.4 Main Business/Business Overview
3.7 Novartis
3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.7.2 Biologics and Biosimilars Product Types, Application and Specification
3.7.2.1 Antibody
3.7.2.2 Hormone
3.7.3 Novartis Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.7.4 Main Business/Business Overview
3.8 Merck
3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.8.2 Biologics and Biosimilars Product Types, Application and Specification
3.8.2.1 Antibody
3.8.2.2 Hormone
3.8.3 Merck Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.8.4 Main Business/Business Overview
3.9 3sbio
3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.9.2 Biologics and Biosimilars Product Types, Application and Specification
3.9.2.1 Antibody
3.9.2.2 Hormone
3.9.3 Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.9.4 Main Business/Business Overview
3.10 Changchun High and New Technology Industry
3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.10.2 Biologics and Biosimilars Product Types, Application and Specification
3.10.2.1 Antibody
3.10.2.2 Hormone
3.10.3 Changchun High and New Technology Industry Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.10.4 Main Business/Business Overview
3.11 CP Guojian Pharmacy
3.12 Biotech Pharma
3.13 Gelgen Biopharma
3.14 Innovent
3.15 Tong Hua Dong Bao Group
3.16 Ganlee
3.17 United Laboratories
Biosimilar
3.1 3sbio
3.2 Changchun High and New Technology Industry
3.3 CP Guojian Pharmacy
3.4 Biotech Pharma
3.5 Gelgen Biopharma
4 China Biologics and Biosimilars Capacity, Production, Revenue, Consumption, Export and Import (2011-2016)
4.1 China Biologics and Biosimilars Capacity, Production and Growth (2011-2016)
4.2 China Biologics and Biosimilars Revenue and Growth (2011-2016)
4.3 China Biologics and Biosimilars Production, Consumption, Export and Import (2011-2016)
5 China Biologics and Biosimilars Production, Revenue (Value), Price Trend by Types
5.1 China Biologics and Biosimilars Production and Market Share by Types (2011-2016)
5.2 China Biologics and Biosimilars Revenue and Market Share by Types (2011-2016)
5.3 China Biologics and Biosimilars Price by Type (2011-2016)
5.4 China Biologics and Biosimilars Production Growth by Type (2011-2016)
6 China Biologics and Biosimilars Market Analysis by Applications
6.1 China Biologics and Biosimilars Consumption and Market Share by Applications (2011-2016)
6.2 China Biologics and Biosimilars Consumption Growth Rate by Applications (2011-2016)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Biologics and Biosimilars Manufacturing Cost Analysis
7.1 Biologics and Biosimilars Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Biologics and Biosimilars
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Biologics and Biosimilars Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Biologics and Biosimilars Major Manufacturers in 2015
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 China Biologics and Biosimilars Market Forecast (2016-2021)
11.1 China Biologics and Biosimilars Capacity, Production, Revenue Forecast (2016-2021)
11.2 China Biologics and Biosimilars Production, Import, Export and Consumption Forecast (2016-2021)
11.3 China Biologics and Biosimilars Production Forecast by Type (2016-2021)
11.4 China Biologics and Biosimilars Consumption Forecast by Application (2016-2021)
11.5 Biologics and Biosimilars Price Forecast (2016-2021)
12 Research Findings and Conclusion
13 Appendix
Disclosure Section
Research Methodology
Data Source
China Disclaimer

List of Tables and Figures 

Figure Picture of Biologics and Biosimilars
Figure China Production Market Share of Biologics and Biosimilars by Types in 2015
Figure Product Picture of Antibody
Table Major Manufacturers of Antibody
Figure Product Picture of Hormone
Table Major Manufacturers of Hormone
Figure Product Picture of Growth Factors
Table Major Manufacturers of Growth Factors
Table Biologics and Biosimilars Consumption Market Share by Applications in 2015
Figure Tumor Examples
Figure Diabetes Examples
Figure Cardiovascular Examples
Figure Hemophilia Examples
Figure Other Examples
Figure China Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2011-2021)
Table China Biologics and Biosimilars Capacity of Key Manufacturers (2015 and 2016)
Table China Biologics and Biosimilars Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Biologics and Biosimilars Capacity of Key Manufacturers in 2015
Figure China Biologics and Biosimilars Capacity of Key Manufacturers in 2016
Table China Biologics and Biosimilars Production of Key Manufacturers (2015 and 2016)
Table China Biologics and Biosimilars Production Share by Manufacturers (2015 and 2016)
Figure 2015 Biologics and Biosimilars Production Share by Manufacturers
Figure 2016 Biologics and Biosimilars Production Share by Manufacturers
Table China Biologics and Biosimilars Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Biologics and Biosimilars Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Biologics and Biosimilars Revenue Share by Manufacturers
Table 2016 China Biologics and Biosimilars Revenue Share by Manufacturers
Table China Market Biologics and Biosimilars Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Biologics and Biosimilars Average Price of Key Manufacturers in 2015
Table Manufacturers Biologics and Biosimilars Manufacturing Base Distribution and Sales Area
Table Manufacturers Biologics and Biosimilars Product Types
Figure Biologics and Biosimilars Market Share of Top 3 Manufacturers
Figure Biologics and Biosimilars Market Share of Top 5 Manufacturers
Table Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amgen Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Amgen Biologics and Biosimilars Market Share (2011-2016)
Table Sanofi-Aventis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi-Aventis Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi-Aventis Biologics and Biosimilars Market Share (2011-2016)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Johnson & Johnson Biologics and Biosimilars Market Share (2011-2016)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Biologics and Biosimilars Market Share (2011-2016)
Table Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novo Nordisk Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Novo Nordisk Biologics and Biosimilars Market Share (2011-2016)
Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Eli Lilly Biologics and Biosimilars Market Share (2011-2016)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis Biologics and Biosimilars Market Share (2011-2016)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Merck Biologics and Biosimilars Market Share (2011-2016)
Table 3sbio Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 3sbio Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure 3sbio Biologics and Biosimilars Market Share (2011-2016)
Table Changchun High and New Technology Industry Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Changchun High and New Technology Industry Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Changchun High and New Technology Industry Biologics and Biosimilars Market Share (2011-2016)
Figure China Biologics and Biosimilars Capacity, Production and Growth (2011-2016)
Figure China Biologics and Biosimilars Revenue (Million USD) and Growth (2011-2016)
Table China Biologics and Biosimilars Production, Consumption, Export and Import (2011-2016)
Table China Biologics and Biosimilars Production by Types (2011-2016)
Table China Biologics and Biosimilars Production Share by Types (2011-2016)
Figure Production Market Share of Biologics and Biosimilars by Types (2011-2016)
Figure 2015 Production Market Share of Biologics and Biosimilars by Types
Table China Biologics and Biosimilars Revenue by Types (2011-2016)
Table China Biologics and Biosimilars Revenue Share by Types (2011-2016)
Figure Production Revenue Share of Biologics and Biosimilars by Types (2011-2016)
Figure 2015 Revenue Market Share of Biologics and Biosimilars by Types
Table China Biologics and Biosimilars Price by Types (2011-2016)
Figure China Biologics and Biosimilars Production Growth by Type (2011-2016)
Table China Biologics and Biosimilars Consumption by Applications (2011-2016)
Table China Biologics and Biosimilars Consumption Market Share by Applications (2011-2016)
Figure China Biologics and Biosimilars Consumption Market Share by Applications in 2015
Table China Biologics and Biosimilars Consumption Growth Rate by Applications (2011-2016)
Figure China Biologics and Biosimilars Consumption Growth Rate by Applications (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biologics and Biosimilars
Figure Manufacturing Process Analysis of Biologics and Biosimilars
Figure Biologics and Biosimilars Industrial Chain Analysis
Table Raw Materials Sources of Biologics and Biosimilars Major Manufacturers in 2015
Table Major Buyers of Biologics and Biosimilars
Table Distributors/Traders List
Figure China Biologics and Biosimilars Capacity, Production and Growth Rate Forecast (2016-2021)
Figure China Biologics and Biosimilars Revenue and Growth Rate Forecast (2016-2021)
Table China Biologics and Biosimilars Production, Import, Export and Consumption Forecast (2016-2021)
Table China Biologics and Biosimilars Production Forecast by Type (2016-2021)
Table China Biologics and Biosimilars Consumption Forecast by Application (2016-2021)

Request sample If you need any reports sample, just let us know.